Ikarian Capital, LLC Inovio Pharmaceuticals, Inc. Transaction History
Ikarian Capital, LLC
- $573 Million
- Q3 2024
A detailed history of Ikarian Capital, LLC transactions in Inovio Pharmaceuticals, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 250,000 shares of INO stock, worth $1.07 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
250,000Holding current value
$1.07 Million% of portfolio
0.14%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding INO
# of Institutions
10Shares Held
281KCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ148KShares$632,1490.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ86.4KShares$367,9190.0% of portfolio
-
Brainard Capital Management LLC Austin, TX16.7KShares$70,9970.01% of portfolio
-
Tiaa, Fsb St. Louis, MO14.4KShares$61,2710.0% of portfolio
-
Personal Capital Advisors Corp11.3KShares$48,1380.0% of portfolio
About INOVIO PHARMACEUTICALS, INC.
- Ticker INO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 249,400,000
- Market Cap $1.06B
- Description
- Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...